New test predicts blood cancer’s sensitivity to experimental cancer drug
Loading...
A test developed by Dana-Farber Cancer Institute scientists is the first to identify which malignant blood cells are highly vulnerable to a promising type of experimental drugs that unleash pent-up “cell suicide” factors to destroy the cancer.
HART still has a lot of work to do ... if you see something that is broken, please bring it to his attention via contact page or inside Facebook! Thanks :D
